aspirin 325 MG / butalbital 50 MG / caffeine 40 MG / codeine phosphate 30 MG Oral Capsule
RxNorm concept 994237, clinical drug (scd). Prescribable name: butalbital 50 MG / aspirin 325 MG / caffeine 40 MG / codeine phosphate 30 MG Oral Capsule.
- RxCUI
- 994237
- Term type
- Clinical drug (SCD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/994237 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
ASA 325 MG / butalbital 50 MG / caffeine 40 MG / codeine phosphate 30 MG Oral Capsule
Related concepts
- aspirin 325 MG (SCDC, consists of)
- butalbital 50 MG (SCDC, consists of)
- caffeine 40 MG (SCDC, consists of)
- codeine phosphate 30 MG (SCDC, consists of)
- Oral Capsule (DF, has dose form)
- aspirin 325 MG / butalbital 50 MG / caffeine 40 MG / codeine phosphate 30 MG Oral Capsule [Ascomp] (SBD, has tradename)
Linked data
NDCs
- 00527131201
- 63629295201
- 63629295202
- 63629295203
- 63629295204
- 63629295205
- 63629295206
- 66267003815
- 68084011400
- 68084011405
- 69238199301
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 994237 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/994237 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 994237. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.